Δευτέρα 5 Δεκεμβρίου 2016

Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo

Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo

Molecular Therapy 24, 1889 (November 2016). doi:10.1038/mt.2016.192

Authors: Yuda Wei, Yanhao Chen, Yan Qiu, Huan Zhao, Gaigai Liu, Yongxian Zhang, Qingyang Meng, Guohao Wu, Yixiong Chen, Xiaolong Cai, Hui Wang, Hao Ying, Bin Zhou, Mingyao Liu, Dali Li & Qiurong Ding



http://ift.tt/2gKzOcC

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου